Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory 2020-01-16 21:00
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany 2020-01-16 10:39
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline" 2020-01-16 07:30
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases 2020-01-09 17:10
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies 2020-01-07 22:00
GPHL's international headquarters settle in Macao, first project during the fifth-term government of Macao SAR 2020-01-06 14:39
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2020-01-03 23:30
Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC 2019-12-27 06:30
Viva Biotech Awarded 'Top 10 Public Companies' 2019-12-24 18:18
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC 2019-12-20 10:19
Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug 2019-12-18 22:00
Dr. Jie Jack Li joins Shanghai ChemPartner as a Vice President of Discovery Chemistry 2019-12-18 00:00
iX Biopharma Reports on Outcome of Wafermine End-of-phase 2 Meeting with US FDA 2019-12-11 22:00
Gracell Announces Progressive Outcomes from Multiple Human Clinical Trials to Investigate FasTCAR and Dual CAR Cell Platform Technologies 2019-12-09 22:00
Hebron Announces $6.5 Million Private Placement 2019-12-09 21:30
BJ Bioscience Announces First Patient Dosed in FIH Trial of BJ-001 in Patients with Locally Advanced/Metastatic Solid Tumors 2019-12-09 21:00
Lumosa Announces FDA Acceptance of IND Application for LT1001, an Extended-Release Analgesic Injection - Lumosa to Initiate the Bridging Study in the US 2019-12-03 17:36
New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority 2019-12-03 05:30
Innovent Presents Co-developed Cancer-Fighting Tyvyt(R) (Sintilimab Injection) at CIIE 2019 with Eli Lilly 2019-12-02 09:37
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park 2019-11-21 11:30
1 117 118 119 120 121 158